Denys-Drash Syndrome is a rare condition that affects how a baby's body develops. It causes problems with the kidneys, the reproductive organs, and sometimes tumors. It's caused by a change in a specific gene.
Every report comes from a Lived member, sent anonymously.
Have you had Kidney Transplant for Denys-Drash Syndrome?
Denys-Drash syndrome is a rare genetic condition that mainly affects the kidneys and the development of the reproductive organs. Its central feature is kidney disease that usually starts within the first months of life. The kidneys' tiny filters become scarred and leak large amounts of protein into the urine, a pattern called nephrotic syndrome, and in most children this leads to kidney failure during childhood. Children with the condition also have a much higher than usual chance of Wilms tumor, a kidney cancer of early childhood that can appear in one or both kidneys. Children with a typical male chromosome pattern (46,XY) usually have differences in sex development: the testes form incompletely and stay undescended, and the external genitals may look neither clearly male nor clearly female, or may look female. Girls with a typical female chromosome pattern (46,XX) usually have typical genitals and only the kidney features, so they are often diagnosed later, sometimes first labelled as having nephrotic syndrome alone. Denys-Drash syndrome is closely related to Frasier syndrome, which involves the same gene but tends to cause slower kidney disease starting later in childhood. Specialists now often describe both as part of one spectrum called WT1 disorder.
Denys-Drash syndrome is caused by a change (variant) in the WT1 gene, named for its link to Wilms tumor. This gene helps switch other genes on and off while the kidneys and gonads (testes or ovaries) form before birth, and it also helps keep kidney cells from growing into tumors. When the WT1 protein cannot work properly, the kidney filters and reproductive organs develop abnormally and the risk of Wilms tumor rises. One altered copy of the gene is enough to cause the condition. In most children the variant is new, arising for the first time in that child rather than being passed down from a parent, so it is not caused by anything parents did during pregnancy. If a parent does carry the variant, each child has a 50 percent chance of inheriting it. When neither parent carries it, the chance of another affected child is low, though slightly higher than in the general population. Once a family's variant is known, relatives can be tested, and testing during pregnancy or of embryos before IVF (in vitro fertilization) transfer is possible.
Denys-Drash syndrome is usually suspected in a baby or young child with heavy protein loss in the urine, especially when it appears very early in life, does not respond to steroid treatment, or comes with differences in genital development or a Wilms tumor. Urine and blood tests measure how much protein is being lost and how well the kidneys are filtering. A kidney ultrasound looks for tumors and other structural changes. The diagnosis is confirmed by genetic testing that finds a disease-causing WT1 variant. For nephrotic syndrome that starts in the first months of life or comes with other features like these, current guidance favors genetic testing as the first step, often making a kidney biopsy unnecessary. A biopsy may still be used when genetic results are unavailable or unclear. For children with differences in genital development, a chromosome test and hormone tests help show how the testes or ovaries have formed. Some boys are now identified through genetic testing for genital differences before any kidney problem appears, which allows monitoring to start early.
There is no treatment that corrects the underlying gene change, so care focuses on protecting the kidneys for as long as possible, catching tumors early, and supporting growth and development. Because the condition touches several organ systems, care is usually led by a team that can include a pediatric kidney specialist (nephrologist), cancer specialist, urologist, endocrinologist, geneticist and psychologist. The kidney disease does not respond to steroids or other immune-suppressing medicines that treat many other forms of childhood nephrotic syndrome, and these drugs are best avoided because they add side effects without benefit. Doctors may instead use blood pressure medicines such as ACE (angiotensin-converting enzyme) inhibitors or angiotensin receptor blockers, which can reduce protein leakage, along with careful management of fluid, salt, nutrition and growth. When the kidneys fail, children need dialysis and, ultimately, a kidney transplant, which offers the best long-term kidney outcome. Doctors often recommend removing both native kidneys before transplant, or earlier if protein loss causes severe complications. Taking out the kidneys also removes the risk of Wilms tumor in them. If a Wilms tumor develops first, it is treated with standard childhood cancer care (surgery, often with chemotherapy), and surgeons try to spare healthy kidney tissue when they can. Undeveloped or undescended testes can develop a tumor called gonadoblastoma, so specialists often recommend removing them as a preventive step. Decisions about genital surgery, sex of rearing and later hormone treatment to support puberty are complex and personal, and they are best made with a specialist team experienced in differences of sex development, with psychological support for the family.
The course varies with the specific gene change and the age at which kidney disease begins. Many children reach kidney failure in infancy or the first few years of life, and some die young from kidney failure or tumor complications, particularly when disease starts very early. Others have a slower course. A French study found that children with variants in one part of the gene (exon 8) reached kidney failure much earlier than those with variants in another part (exon 9), so the specific variant can help families and doctors anticipate what lies ahead. While the native kidneys remain, children are usually checked for Wilms tumor with an abdominal ultrasound about every three months until around age seven, because tumors found while small are easier to treat and more of the kidney can be saved. Children found through genetic testing before kidney disease starts also have their urine checked for protein, about every six months until age ten and yearly after that. Life with dialysis and then a transplant brings frequent appointments, medicines to prevent rejection and close attention to growth and nutrition. Most people with WT1 disorder have reduced function of the testes or ovaries in adolescence or adulthood, which can delay or limit puberty and usually affects fertility, so hormone checks become part of follow-up after puberty. Ongoing emotional support for the child and family matters through each of these stages.
Ask for a genetic evaluation when a baby or young child has heavy protein loss in the urine, especially if it began very early, did not respond to steroids, or occurs alongside differences in genital development or a kidney tumor. A family member of someone with a known WT1 variant can also ask about testing. For a child with the condition or a known WT1 variant, contact the care team promptly about a new lump or swelling in the belly or blood in the urine, since these can be signs of Wilms tumor. Puffiness around the eyes, swollen legs or feet, or foamy urine in a child not yet being treated for kidney disease also deserves a call, as these are common signs of protein loss. Children on dialysis or after transplant should follow the specific instructions their kidney team gives for fever, reduced urine or other changes.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Denys-Drash Syndrome is like, what's helped you, or ask the community a question.